10 studies found for:    "Riociguat (BAY63-2521)"
Show Display Options
Rank Status Study
1 Terminated A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Placebo
2 Completed Relative Bioavailability and Food Effect Study
Condition: Biological Availability
Intervention: Drug: Riociguat (BAY63-2521)
3 Withdrawn Coronary Vasomotor Response After Riociguat Exposure
Condition: Coronary Artery Disease
Intervention: Drug: Riociguat (BAY63-2521)
4 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
5 Completed Effect of Riociguat on Bone Metabolism
Condition: Effect of Riociguat on Bone Metabolism,
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Placebo
6 Completed Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (BAY63-2521)
7 Active, not recruiting BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (BAY63-2521)
8 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
9 Active, not recruiting
Has Results
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
10 Terminated
Has Results
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo

Indicates status has not been verified in more than two years